TY - JOUR
T1 - Vitamin D and Cardiovascular Disease
T2 - Can Novel Measures of Vitamin D Status Improve Risk Prediction and Address the Vitamin D Racial Paradox?
AU - Kim, Samuel M.
AU - Lutsey, Pamela L.
AU - Michos, Erin D.
N1 - Publisher Copyright:
© 2017, Springer Science+Business Media New York.
PY - 2017/1/1
Y1 - 2017/1/1
N2 - Purpose of Review: The major focus of this review article is to provide a state-of-the-art update on some emerging measures of vitamin D status and discuss how assessment of these key vitamin D metabolites might improve prognostication of risk for cardiovascular disease (CVD) outcomes. Recent Findings: Vitamin D deficiency is a highly prevalent condition and relatively easy to treat with supplementation and/or modest sunlight exposure. A substantial body of experimental and epidemiological evidence suggests that vitamin D deficiency is a risk factor for CVD. Most epidemiologic studies to date have focused on total 25-hydroxyvitamin D [25(OH)D] concentrations, which is the established marker of vitamin D stores. However, there is emerging evidence that other novel markers of vitamin D metabolism may better characterize “true” vitamin D status. Some key novel measures include bioavailable 25(OH)D, free 25(OH)D, 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D3 [24,25(OH)2D3], and ratio of 24,25(OH)2D3 to 25(OH)D [the vitamin D metabolic ratio]. Utilization of these biomarkers may enhance understanding of the association between vitamin D and CVD risk and may provide explanation for the observation that 25(OH)D is a stronger CVD risk factor in Whites than Blacks. Summary: Novel measures of vitamin D status could potentially change clinical practice regarding how patients are currently screened for vitamin D status and defined as vitamin D deficient or not. However, whether measuring any of these alternate markers of vitamin D status can provide further insight regarding CVD risk beyond the traditionally measured 25(OH)D concentrations is uncertain at this time. This is an area where further research is strongly needed.
AB - Purpose of Review: The major focus of this review article is to provide a state-of-the-art update on some emerging measures of vitamin D status and discuss how assessment of these key vitamin D metabolites might improve prognostication of risk for cardiovascular disease (CVD) outcomes. Recent Findings: Vitamin D deficiency is a highly prevalent condition and relatively easy to treat with supplementation and/or modest sunlight exposure. A substantial body of experimental and epidemiological evidence suggests that vitamin D deficiency is a risk factor for CVD. Most epidemiologic studies to date have focused on total 25-hydroxyvitamin D [25(OH)D] concentrations, which is the established marker of vitamin D stores. However, there is emerging evidence that other novel markers of vitamin D metabolism may better characterize “true” vitamin D status. Some key novel measures include bioavailable 25(OH)D, free 25(OH)D, 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D3 [24,25(OH)2D3], and ratio of 24,25(OH)2D3 to 25(OH)D [the vitamin D metabolic ratio]. Utilization of these biomarkers may enhance understanding of the association between vitamin D and CVD risk and may provide explanation for the observation that 25(OH)D is a stronger CVD risk factor in Whites than Blacks. Summary: Novel measures of vitamin D status could potentially change clinical practice regarding how patients are currently screened for vitamin D status and defined as vitamin D deficient or not. However, whether measuring any of these alternate markers of vitamin D status can provide further insight regarding CVD risk beyond the traditionally measured 25(OH)D concentrations is uncertain at this time. This is an area where further research is strongly needed.
KW - Biomarker
KW - Cardiovascular risk factor
KW - Vitamin D
UR - http://www.scopus.com/inward/record.url?scp=85010060594&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85010060594&partnerID=8YFLogxK
U2 - 10.1007/s12170-017-0528-7
DO - 10.1007/s12170-017-0528-7
M3 - Review article
C2 - 28261371
AN - SCOPUS:85010060594
SN - 1932-9520
VL - 11
JO - Current Cardiovascular Risk Reports
JF - Current Cardiovascular Risk Reports
IS - 1
M1 - 3
ER -